Alexion Pharmaceuticals, Inc.
Elliott Management Is Said Push for Changes at Alexion - The New York Times
AstraZeneca's Alexion halts ALS trial on lack of efficacy | Reuters
Alexion Pharmaceuticals Inc. moving headquarters to Boston
Alexion Says FDA Grants Orphan Drug Designation To ALXN1210 | World Pharma Today
Alexion Pharma's Bloated Blockbuster Deal Still Haunts - TheStreet
Alexion to Acquire Wilson Therapeutics | Business Wire
Alexion Pharmaceuticals' (ALXN) Highest Price: $207.84 (on 07-23-2015)
Alexion Ends Rare Kidney Disease Program Following Poor Data | BioSpace
Lessons We Can Learn from Alexion's Departure » CBIA
Alexion Pharma | Fierce Pharma
DFWHC and Alexion webinar “Beyond the Pill with Pharma” set for April 14! | DFWHC
Alexion Pharmaceuticals, Inc. - YouTube
Alexion Pharma Stock Dives On Report It's Under Federal Scrutiny | Investor's Business Daily
AZ's rare disease Ultomiris snags 3rd FDA nod
Alexion acquiring Achillion to expand reach into rare disease
Alexion Pharma to pay $8.4 billion for Synageva BioPharma
Articles with Alexion
Sep 21, 2020 South San Francisco / CA / USA - Alexion logo at their headquarters in Silicon Valley; Alexion Pharmaceuticals, Inc. develops treatments Stock Photo - Alamy
Alexion Pharmaceuticals, Inc. signs to 150,000 s/f lease at Skanska's 121 Seaport : NEREJ
Alexion Pharmaceuticals - Crunchbase Company Profile & Funding
